Acadian Asset Management’s AC Immune ACIU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $820K | Buy |
411,696
+40,519
| +11% | +$80.7K | ﹤0.01% | 1018 |
|
|
2025
Q1 | $679K | Buy |
371,177
+172,796
| +87% | +$316K | ﹤0.01% | 1011 |
|
|
2024
Q4 | $528K | Buy |
198,381
+152,369
| +331% | +$406K | ﹤0.01% | 1063 |
|
|
2024
Q3 | $172K | Buy |
+46,012
| New | +$172K | ﹤0.01% | 1414 |
|
|
2023
Q2 | – | Sell |
-3,845
| Closed | -$8K | – | 1701 |
|
|
2023
Q1 | $8K | Buy |
+3,845
| New | +$8K | ﹤0.01% | 1692 |
|
|
2021
Q4 | – | Sell |
-107,093
| Closed | -$717K | – | 1653 |
|
|
2021
Q3 | $717K | Sell |
107,093
-117,398
| -52% | -$786K | ﹤0.01% | 944 |
|
|
2021
Q2 | $1.78M | Sell |
224,491
-51,929
| -19% | -$412K | 0.01% | 746 |
|
|
2021
Q1 | $2.1M | Sell |
276,420
-386,092
| -58% | -$2.94M | 0.01% | 717 |
|
|
2020
Q4 | $3.43M | Sell |
662,512
-191,368
| -22% | -$989K | 0.01% | 605 |
|
|
2020
Q3 | $4.17M | Buy |
853,880
+84,828
| +11% | +$414K | 0.02% | 482 |
|
|
2020
Q2 | $5.18M | Buy |
769,052
+21,271
| +3% | +$143K | 0.02% | 479 |
|
|
2020
Q1 | $5.16M | Buy |
747,781
+426,542
| +133% | +$2.95M | 0.03% | 393 |
|
|
2019
Q4 | $2.74M | Buy |
321,239
+173,555
| +118% | +$1.48M | 0.01% | 586 |
|
|
2019
Q3 | $729K | Buy |
147,684
+59,191
| +67% | +$292K | ﹤0.01% | 985 |
|
|
2019
Q2 | $492K | Buy |
+88,493
| New | +$492K | ﹤0.01% | 1021 |
|